Advanced hepatocellular carcinoma and sorafenib: Diagnosis, indications, clinical and radiological follow-up

Figure 1 Main therapeutic options for advanced hepatocellular carcinoma treatment. TACE: Trans-arterial chemo-embolization; TARE: Trans-arterial radio embolization; PST: Performance status; PVT: Portal vein thrombosis.

Figure 2 Computed tomography and magnetic resonance imaging examination at baseline and one month after the start of sorafenib therapy of patient showing progressive disease. A: Arterial phase computed tomography (CT); B: Venous phase CT; C: Magnetic resonance imaging diffusion weighted imaging. ADC: Apparent diffusion coefficient.

Figure 3 Computed tomography and magnetic resonance imaging examination at baseline and one month after the start of sorafenib therapy of a patient showing partial response. A: Arterial phase computed tomography (CT); B: Venous phase CT; C: Magnetic resonance imaging diffusion weighted imaging. ADC: Apparent diffusion coefficient.